Michael P. Miller

Michael P. Miller has extensive experience in the biotechnology and pharmaceuticals sectors, currently serving as a Member of the Board of Directors for Puma Biotechnology, Inc. and BioXcel Therapeutics, Inc., where responsibilities include roles on the Nomination and Corporate Governance Committee, Compensation Committee, and Audit Committee. Additionally, Miller holds strategic advisory positions at Rigel Pharmaceuticals Inc., Healthyr, and Concarlo Therapeutics. Previous leadership roles include Executive Board Member at The Leukemia & Lymphoma Society and Executive Vice President and Senior Vice President positions at Jazz Pharmaceuticals and VIVUS, Inc., respectively. Miller's career began at Genentech and Stiefel, a GSK company. Educational credentials include an MBA in Management Information Systems from San Francisco State University and a BS in Finance from the University of San Francisco.